Vancouver, British Columbia–(Newsfile Corp. – December 13, 2021) – Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) (“ Lobe” or the “Company“) is pleased to announce that it has received approval from OTC Markets Group Inc. (“OTCM”) for its shares to trade on the OTCQB®. Lobe Sciences’ common stock will commence trading on the OTCQB under the symbol “LOBEF” at the opening of the market on December 13…


Previous articleCOMPASS Pathways announces positive outcome of 25mg COMP360 psilocybin therapy as adjunct to SSRI antidepressants in open-label treatment-resistant depression study
Next articleMINDCURE Appoints Dr. Doron Sagman as Chief Medical Officer